Ro logoCompany profile

Ro

Ro (Roman Health Ventures) is a direct-to-consumer telehealth company offering treatments for men's and women's health, weight loss (including GLP-1s), fertility and dermatology through subsidiaries Roman, Rory, Zero and Modern Fertility. Founded in 2017 and headquartered in New York, Ro has raised approximately $1B at a $7B valuation, most recently in a 2022 Series D.

Back to profiles

Company snapshot

  • Active
Total funding
$1.0B
Funding rounds
7
Last round (Series D)
$150M
Last round date
Mar 2022
Founded
2017
Employees
501-1000
Headquarters
New York, New York, United States
Last round vs total raised$150M of $1.0B

Founders

Zachariah Reitano, Saman Rahmanian, Rob Schutz

Industries

  • Telehealth
  • Healthcare
  • Direct-to-Consumer
  • Digital Health

Notable investors

This table scrolls sideways on small screens.

InvestorRole
General CatalystLead
FirstMark CapitalLead
TQ VenturesCo-investor
ShawSpring PartnersLead
Initialized CapitalCo-investor
BoxGroupCo-investor

Frequently asked questions

Ro has raised $1.0B in total funding across 7 rounds.

Ro's most recent round was a Series D of $150M in Mar 2022.

Ro was founded in 2017.

Ro is headquartered in New York, New York, United States.

Ro has 501-1000 employees.

Ro's notable investors include General Catalyst, FirstMark Capital, TQ Ventures, ShawSpring Partners, Initialized Capital, BoxGroup.

Reach buyers like Ro.

The 14-day trial ships every feature, no card required.

Start free →